SBX

Synbiotic SE

  • Germany
  • Healthcare
  • Pharma
Metrics score locked — part of Premium
FY20
FY21
FY22
FY23
FY24
FY20 – FY24

Assets

(positive)
Change from FY20 to FY24
millions EUR
FY20:
7.69
FY21:
10.6
FY22:
8.05
FY23:
6.53
FY24:
6.87
(positive)
Change from FY20 to FY24
millions EUR
FY20:
27.3
FY21:
50.1
FY22:
32.6
FY23:
28.4
FY24:
38.8
Total assets
Change from FY20 to FY24
millions EUR
FY20:
35.0
FY21:
60.6
FY22:
40.6
FY23:
34.9
FY24:
45.7

Liabilities & Equity

(negative)
Change from FY20 to FY24
millions EUR
FY20:
9.21
FY21:
4.97
FY22:
5.74
FY23:
8.02
FY24:
15.5
(negative)
Change from FY20 to FY24
millions EUR
FY20:
0.32
FY21:
18.9
FY22:
12.1
FY23:
11.6
FY24:
9.25
(positive)
Change from FY20 to FY24
millions EUR
FY20:
25.5
FY21:
36.7
FY22:
22.8
FY23:
15.3
FY24:
21.0
Total liabilities & equity
Change from FY20 to FY24
millions EUR
FY20:
35.0
FY21:
60.6
FY22:
40.6
FY23:
34.9
FY24:
45.7

All amounts in millions EUR Data source:Twelve Data